CD38 in Advanced Prostate Cancers

BACKGROUND: CD38, a druggable ectoenzyme, is involved in the generation of adenosine, which is implicated in tumour immune evasion. Its expression and role in prostate tumour-infiltrating immune cells (TIICs) have not been elucidated. OBJECTIVE: To characterise CD38 expression on prostate cancer (PC...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Christina, Crespo, Mateus, Gurel, Bora, Dolling, David, Rekowski, Jan, Sharp, Adam, Petremolo, Antonella, Sumanasuriya, Semini, Rodrigues, Daniel N., Ferreira, Ana, Pereira, Rita, Figueiredo, Ines, Mehra, Niven, Lambros, Maryou B.K., Neeb, Antje, Gil, Veronica, Seed, George, Terstappen, Leon, Alimonti, Andrea, Drake, Charles G., Yuan, Wei, de Bono, Johann S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2021
Materias:
Platinum Priority – Prostate Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175332/
https://www.ncbi.nlm.nih.gov/pubmed/33678520
http://dx.doi.org/10.1016/j.eururo.2021.01.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175332/
https://www.ncbi.nlm.nih.gov/pubmed/33678520
http://dx.doi.org/10.1016/j.eururo.2021.01.017

Ejemplares similares